CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...
Phase 2
Rochester, Minnesota, United States and 8 other locations
This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...
Phase 2
Rochester, Minnesota, United States and 3 other locations
triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...
Phase 2
Rochester, Minnesota, United States and 9 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Rochester, Minnesota, United States and 9 other locations
This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...
Phase 2
Rochester, Minnesota, United States and 36 other locations
This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and whi ...
Phase 2
Rochester, Minnesota, United States and 4 other locations
In this research study we are studying the effects of the combination of lapatinib plus Herceptin in subjects with breast cancer th...
Phase 2
Rochester, Minnesota, United States and 8 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Rochester, Minnesota, United States and 117 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Rochester, Minnesota, United States and 32 other locations
with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...
Phase 2
Rochester, Minnesota, United States
Clinical trials
Research sites
Resources
Legal